cancer reserach
Time to complete this course:
2.5 hours
Date of publication:
Nov 2018

After completing the course the learner will:

  • Understand the epidemiology of hepatitis B and C and how to assess the risk of hepatitis B and C for a patient.
  • Understand the new treatment options for hepatitis C, and their success rates.
  • Know when patients with hepatitis B and C should be referred, or re-referred, to secondary care in view of changes in treatment options.
  • Be confident in communicating with patients to assess risk, discuss testing and giving results.
  • Know how to manage patients with chronic hepatitis before, during and after their treatment.

This course was developed in partnership with Gilead Sciences